PET Imaging of 18F-(2S,4R)4-Fluoroglutamine Accumulation in Breast Cancer: From Xenografts to Patients-Reference-Cited by-同舟云学术

PET Imaging of 18F-(2S,4R)4-Fluoroglutamine Accumulation in Breast Cancer: From Xenografts to Patients

Published:2018-07-09 Issue:8 Volume:15 Page:3448-3455
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Liu Fei¹,Xu Xiaoxia¹,Zhu Hua¹,Zhang Yan²,Yang Jianhua¹,Zhang Lifang²,Li Nan¹,Zhu Lin²,Kung Hank F.³⁴,Yang Zhi¹^ORCID

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing 100142, China

2. Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China

3. Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States

4. Beijing Institute for Brain Disorders, Capital Medical University, Beijing 100069, China

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Beijing Municipal Commission of Health and Family Planning

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00430

Reference29 articles.

1. Cancer statistics in China, 2015

2. Otto Warburg's contributions to current concepts of cancer metabolism

3. The Warburg Effect: How Does it Benefit Cancer Cells?

4. Diagnostic Accuracy of 18F-FDG-PET and PET/CT in the Differential Diagnosis between Malignant and Benign Pleural Lesions

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET Imaging of Metabolism, Perfusion, and Hypoxia;The Cancer Journal;2024-05

2. The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook;Journal of Nuclear Medicine;2024-05

3. KRAS Mutation Detection with (2S,4R)-4-[¹⁸F]FGln for Noninvasive PDAC Diagnosis;Molecular Pharmaceutics;2024-03-08

4. Evaluation of (2S,4S)-4-[¹⁸F]FEBGln as a Positron Emission Tomography Tracer for Tumor Imaging;Molecular Pharmaceutics;2023-08-30

5. PET Oncological Radiopharmaceuticals: Current Status and Perspectives;Molecules;2022-10-11